BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Zynerba Pharmaceuticals, Inc. (Nasdaq - ZYNE), Chindata Group Holdings Limited (Nasdaq - CD), Capri Holdings Limited (NYSE – CPRI), Avid® (Nasdaq - AVID)
BALA CYNWYD, Penn., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.
- BALA CYNWYD, Penn., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.
- If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
- Under the terms of the Agreement, Zynerba will be acquired by Harmony Biosciences Holdings, Inc. (“Harmony”) (Nasdaq - HRMY).
- Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits.